Universal regimens or universal access to drug susceptibility testing for tuberculosis?
Journal
The Lancet. Infectious DiseasesPublisher
ElsevierPubMed ID
30744961Type
ArticleOther
Language
enEISSN
1474-4457ae974a485f413a2113503eed53cd6c53
10.1016/S1473-3099(18)30742-4
Scopus Count
Collections
Related articles
- Drug resistance mechanisms and drug susceptibility testing for tuberculosis.
- Authors: Miotto P, Zhang Y, Cirillo DM, Yam WC
- Issue date: 2018 Dec
- Management of drug-resistant tuberculosis.
- Authors: Lange C, Dheda K, Chesov D, Mandalakas AM, Udwadia Z, Horsburgh CR Jr
- Issue date: 2019 Sep 14
- Concordance of Mycobacterium tuberculosis fluoroquinolone resistance testing: implications for treatment.
- Authors: Farhat MR, Mitnick CD, Franke MF, Kaur D, Sloutsky A, Murray M, Jacobson KR
- Issue date: 2015 Mar
- The Coming of Age of Drug-Susceptibility Testing for Tuberculosis.
- Authors: Cox H, Mizrahi V
- Issue date: 2018 Oct 11
- Drug Resistance of Mycobacterium tuberculosis Complex in a Rural Setting, Angola.
- Authors: Rando-Segura A, Aznar ML, Moreno MM, Espasa M, Sulleiro E, Bocanegra C, Gil E, Eugénio ANE, Escartin C, Zacarias A, Vegue J, Katimba D, Vivas MC, Gabriel E, Marina MC, Mendioroz J, López MT, Pumarola T, Molina I, Tórtola MT
- Issue date: 2018 Mar